A Study to Examine the Acceptable Taste and to Estimate the Amount of Atazanavir and Cobicistat in the Body When Taken as a Combination Product Versus When Taken as Separate Products at the Same Time

For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com. Inclusion Criteria: * Body mass index (BMI) of 18.0 to 32.0 kg/m2, inclusive. * Women and men must agree to follow specific methods of contraception, if applicable. Exclusion Criteria: * History of a clinically significant drug rash or Stevens-Johnson Syndrome * History of Gilbert's Syndrome * Current or recent (within 3 months of administration) gastrointestinal disease that could impact upon the absorption of study treatment * Any major surgery within 4 weeks of study treatment administration * Any gastrointestinal surgery that could impact upon the absorption of study treatment Other protocol-defined inclusion/exclusion criteria apply